… Overall, this systematic review included data obtained from studies that enrolled 8,655 COPD
patients: 12 studies were double-blind randomized controlled trials (RCTs) (69.4% patients…

… through the Newcastle-Ottawa Quality Assessment Scale (NOS) (Citation25) according to
the procedures recommended in the Cochrane Handbook of Systematic Reviews. JEA and JG …

… analysis to evaluate the efficacy and safety of FP/FORM compared with FP/SAL in treating
pediatric asthma during a 12-week treatment … approval was required for this systematic review. …

… however, evidence also supports that fluticasone is 25% more potent … for treating COPD
exacerbations remains controversial. … Evaluation of human health in patients with COPD remains …

… the inclusion criteria were assessed for methodologic quality by using the appropriate tool
from the list of study quality assessment tools developed by the National Institutes of Health. …

… was assessed using the concise critical appraisal checklists provided by the National Institute
for Health and Care Excellence (NICE) in the single technology appraisal user guide [21]. …

… be thoroughly evaluated before ICS treatment. In this systematic review and meta-analysis,
we … umeclidinium added to fluticasone propionate/salmeterol in patients with COPD: results of …

… These treatments are imperative for patients suffering from COPD, … analysis aiming to
evaluate the safety and efficacy of triple versus dual inhaler therapy in patients with frequent COPD …

… ) who continue to exacerbate despite treatment with dual therapy (LABA/LAMA). A number
… -benefit profile for treatment. We also evaluated and compared study designs and population …

… The present systematic review attempts to evaluate the efficacy and safety of FF in comparision
… propionate/salmeterol: a real-life effectiveness and cost impact evaluation. Respir Med. …